Abstract
Electronic cigarettes (e-cigarettes) have surged in popularity since their introduction in 2007. Sales of e-cigarettes and related products in the US were expected to exceed $1B in 2013. With the popularity of the electronic cigarette on the rise, physicians are sure to get questions from patients about the safety of e-cigarettes and their effectiveness as tools for smoking cessation or reduction. Most users of the electronic cigarette are so-called dual users—current cigarette smokers who also use e-cigarettes. The appeal of these devices is largely based on a perception that they are not as harmful as traditional cigarettes. Other factors that contribute to the popularity of e-cigarettes are that they have the look and feel of a traditional cigarette, that they can be used in locations where cigarette smoking is forbidden, and that they are perceived by smokers as tools to help to reduce or eliminate the smoking of traditional cigarettes. At present, e-cigarettes are not formally regulated for safety or quality control. As a result, nicotine delivery with these devices is not consistent. There is significant concern in the medical community that these e-cigarettes may not be as safe as is publicly perceived, particularly in the context of dual use. The use of e-cigarettes in harm-reduction strategies is a very divisive one in the public health arena. During the last few years, there have been longitudinal, cross-sectional, and randomized clinical trials evaluating the efficacy of electronic cigarettes as smoking cessation aids. This review presents a focused analysis of these studies.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
McAuley TR, Hopke PK, Zhao J, Babaian S. Comparison of the effects of e-cigarette vapor and cigarette smoke on indoor air quality. Inhal Toxicol. 2012;24(12):850–7.
Pellegrino RM, Tinghino B, Mangiaracina G, Marani A, Vitali M, Protano C, et al. Electronic cigarettes: an evaluation of exposure to chemicals and fine particulate matter (PM). Ann Ig Med Prev Comun. 2012;24(4):279–88.
Schripp T, Markewitz D, Uhde E, Salthammer T. Does e-cigarette consumption cause passive vaping? Indoor Air. 2013;23(1):25–31.
Schivo M, Avdalovic MV, Murin S. Non-cigarette tobacco and the lung. Clin Rev Allergy Immunol. 2014;46(1):34–53.
Etter JF. Levels of saliva cotinine in electronic cigarette users. Addiction. 2014;109(5):825–9.
Dawkins L, Turner J, Hasna S, Soar K. The electronic-cigarette: effects on desire to smoke, withdrawal symptoms and cognition. Addict Behav. 2012;37(8):970–3.
Bahl V, Lin S, Xu N, Davis B, Wang YH, Talbot P. Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol. 2012;34(4):529–37.
Agency UEP. Toxilogical Review of Acrolein: http://www.epa.gov/iris/toxreviews/0364tr.pdf. In: Agency EP, editor. Washington, DC 2003. p. 9–11.
Sleiman M, Gundel LA, Pankow JF, Jacob 3rd P, Singer BC, Destaillats H. Formation of carcinogens indoors by surface-mediated reactions of nicotine with nitrous acid, leading to potential thirdhand smoke hazards. Proc Natl Acad Sci U S A. 2010;107(15):6576–81.
Hang B, Sarker AH, Havel C, Saha S, Hazra TK, Schick S, et al. Thirdhand smoke causes DNA damage in human cells. Mutagenesis. 2013;28(4):381–91.
Callahan-Lyon P. Electronic cigarettes: human health effects. Tob Control. 2014;23 Suppl 2:ii36–40.
Agaku IT, King BA, Husten CG, Bunnell R, Ambrose BK, Hu SS, et al. Tobacco product use among adults - United States, 2012-2013. MMWR Morb Mortal Wkly Rep. 2014;63(25):542–7.
Nasim A, Khader Y, Blank MD, Cobb CO, Eissenberg T. Trends in alternative tobacco use among light, moderate, and heavy smokers in adolescence, 1999-2009. Addict Behav. 2012;37(7):866–70.
Etter JF, Bullen C. Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction. 2011;106(11):2017–28.
Berg CJ, Haardoerfer R, Escoffery C, Zheng P, Kegler M. Cigarette users’ interest in using or switching to electronic nicotine delivery systems or smokeless tobacco for harm reduction, cessation, or novelty: a cross-sectional survey of U.S. adults. Nicotine Tob Res Off J Soc Res Nicotine Tob. 2014.
Steinberg MB, Zimmermann MH, Delnevo CD, Lewis MJ, Shukla P, Coups EJ, et al. E-cigarette versus nicotine inhaler: comparing the perceptions and experiences of inhaled nicotine devices. J Gen Intern Med. 2014.
Popova L, Ling PM. Alternative tobacco product use and smoking cessation: a national study. Am J Public Health. 2013;103(5):923–30.
Brown J, Beard E, Kotz D, Michie S, West R. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction. 2014.
Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L. Nicotine levels in electronic cigarettes. Nicotine Tob Res Off J Soc Res Nicotine Tob. 2013;15(1):158–66.
Goniewicz ML, Hajek P, McRobbie H. Nicotine content of electronic cigarettes, its release in vapour and its consistency across batches: regulatory implications. Addiction. 2014;109(3):500–7.
Richardson A, Pearson J, Xiao H, Stalgaitis C, Vallone D. Prevalence, harm perceptions, and reasons for using noncombustible tobacco products among current and former smokers. Am J Public Health. 2014;104(8):1437–44.
Adkison SE, O’Connor RJ, Bansal-Travers M, Hyland A, Borland R, Yong HH, et al. Electronic nicotine delivery systems: international tobacco control four-country survey. Am J Prev Med. 2013;44(3):207–15.
Vickerman KA, Carpenter KM, Altman T, Nash CM, Zbikowski SM. Use of electronic cigarettes among state tobacco cessation quitline callers. Nicotine Tob Res Off J Soc Res Nicotine Tob. 2013;15(10):1787–91.
Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Circulation. 2014;129(19):1972–86. This scientific review provides an up-to-date and comprehensive look at many issues surrounding electronic cigarettes. Topics range from chemical analysis, cytologic studies, particulate analysis, nicotine absorption, and health effects including effects on cigarette smoking cessation. The authors finish with a discussion of how the available evidence should inform public health initiatives.
Grana RA, Popova L, Ling PM. A longitudinal analysis of electronic cigarette use and smoking cessation. JAMA Intern Med. 2014;174(5):812–3.
Etter JF, Bullen C. A longitudinal study of electronic cigarette users. Addict Behav. 2014;39(2):491–4. This observational, longitudinal study identifies two important populations that may benefit from ENDS device use to quit smoking. First, by selecting people who browse ENDS websites, the authors may have identified a group who are more likely to quit conventional smoking using ENDS. Second, the study indicated that longer-term e-cigarette use, i.e. a year rather than weeks, may result in improved cessation rates. This study may inform future randomized trials.
Caponnetto P, Auditore R, Russo C, Cappello GC, Polosa R. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health. 2013;10(2):446–61.
Aubin HJ, Rollema H, Svensson TH, Winterer G. Smoking, quitting, and psychiatric disease: a review. Neurosci Biobehav Rev. 2012;36(1):271–84.
de Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res. 2005;76(2–3):135–57.
Adler LE, Hoffer LD, Wiser A, Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry. 1993;150(12):1856–61.
George TP, Vessicchio JC, Termine A, Sahady DM, Head CA, Pepper WT, et al. Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2002;26(1):75–85.
Polosa R, Morjaria JB, Caponnetto P, Campagna D, Russo C, Alamo A, et al. Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Intern Emerg Med. 2013.
Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013;8(6):e66317.
Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013;382(9905):1629–37. This randomized controlled trial was well-conducted and led to important findings in the field of ENDS for smoking cessation. Though it was underpowered, the trial underscored that single interventions for smoking cessation are likely inadequate and that e-cigarettes may be more accepted than nicotine replacement therapy for many users (perhaps because of the behavioral aspect e-cigarettes provide).
Walker NK, Howe C, Bullen C, Grigg M, Glover M, McRobbie H, et al. Study protocol for a randomised trial of nicotine-free cigarettes as an adjunct to usual NRT-based cessation practice, in people who wish to stop smoking. BMC Public Health. 2011;11:37.
Hughes JR, Shiffman S, Callas P, Zhang J. A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tob Control. 2003;12(1):21–7.
Schraufnagel DE, Blasi F, Drummond MB, Lam DC, Latif E, Rosen MJ, et al. Electronic cigarettes: a position statement of the forum of international respiratory societies. Am J Respir Crit Care Med. 2014.
Compliance with Ethics Guidelines
Conflict of Interest
Dr. Schivo, Dr. Avdalovic, and Dr. Murin report that there are no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schivo, M., Avdalovic, M.V. & Murin, S. Electronic nicotine delivery systems for smoking cessation: where are we?. Curr Respir Care Rep 3, 192–199 (2014). https://doi.org/10.1007/s13665-014-0088-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13665-014-0088-y